Baby heart ultrasound study in newborn congenital heart defects
Part of Genetic & congenital, Heart & circulation clinical trials.
This study records newborn heart measurements (using medical imaging) to compare babies with certain congenital heart defects to healthy-term babies. The goal is to see how well one test matches another, which may help doctors better understand heart conditions in newborns.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born with a specific congenital heart problem (one of the listed conditions)
- Your baby is admitted to the NICU at Montreal Children’s Hospital during the study period (Jan 2018–Jan 2020)
- Your baby was born at 34 weeks of pregnancy or later
- Parents can give permission to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a coordinated treatment plan for newborns with critical congenital heart disease, starting before birth and continuing after delivery. It aims to improve outcomes for babies who need two-ventricle repair surgery.
This study uses automated ultrasound measurements to track how a baby’s heart is working during pregnancy. It compares babies who have a specific congenital heart problem with babies without it, to understand what ultrasound can detect.
This study looks at how blood flow and heart rhythm may affect exercise ability in people born with certain heart defects that have been repaired or treated. It uses a specialized heart MRI and ultrasound measurements to better understand these problems and their causes.
This study is a registry that collects information from adults in Canada who are referred for certain congenital heart procedures. It helps doctors understand which treatments are used and how patients do afterward.
This study collects and analyzes small samples of heart tissue during specific heart operations in babies or children. The goal is to better understand how the heart develops after birth, which could improve future care.
This study looks at tiny particles from cells in newborns with heart defects to understand blood clot risks. It aims to find ways to prevent clots after heart surgery.
Hear when a new Single-ventricle trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.